DermaLabs

DermaLabs

Upcoming
DAO
Aging
$SKIN

DermaLabs blends dermatologist-led science with community-powered research. Using decentralized trials, AI imaging, and SKIN token incentives, we turn everyday skincare into measurable evidence. Together, we build transparent, inclusive, and accountable pathways for discovering and validating what truly works for your skin.

Community Sentiment

How do you feel about this dao?

...
No trend data
...
Community Size
...
Growth Rate
Community
Feed
...
Project

Market Overview

$198 Billion
Global skincare industry in 2025
3 Billion
Individuals affected by skin disease
83%
People globally believing that appearance is important for general wellbeing

DermaLabs explores whether a community-governed model can accelerate and improve skincare innovation. By combining expert formulation, real-world data collection, and open analysis, we test if decentralized evidence generation can guide better products, more representative research, and faster iteration than traditional R&D pipelines. Skincare remains dominated by opaque claims, limited testing, and research that rarely reflects real users. Key biological drivers of skin aging and irritation are well known, yet products are validated inconsistently and exclude diverse skin tones, ages, and diagnoses. Without transparent evidence or participatory science, consumers are left guessing what actually works. DermaLab creates a pathway where users and scientists jointly shape discovery. Through tokenized incentives, stratified analyses, and open dashboards, real-world data becomes a shared resource that drives funding decisions and formulation updates. This model aims to democratize dermatology, elevate evidence standards, and expand access to solutions that meaningfully improve skin health.

Future IP Directions

- Compositions & Methods: C+E+ferulic acid variants, formulation potency.

- Analytics & Tooling: SkinScan models, standardized capture protocols, trial code.

- Licensing & Spin-outs: royalty-sharing for DTC, partnerships, and SKUs.

- Governance IP: token-gated data access, commons stewardship, and reproducibility standards.

Jez Marston, PhD

Physician-scientist and entrepreneur with a PhD in Immunology and Computational Biology from Cornell University. Previous scientific training at Yale and the University of Cambridge. Extensive experience in cell biology, genetics, biopharma, drug development, life science investing across the United States, UK and EU with a focus on translational science and innovation in dermatology, skincare, and longevity.

Dongsinne Sohn

At the crossroads of health and Web3, Dongsinne is a French-Korean entrepreneur who has previously built a skincare company for children suffering from eczema (atopic dermatitis) and has managed major crypto events worldwide for a decade. She is now weaving skin, science, and community into a new paradigm for skin health, bridging cultures and technologies to imagine a future where innovation heals beyond boundaries.

Dr. Hongseok Kim

Korean board-certified dermatologist and MD, known on YouTube as “피부를 알려주는 남자 (Dr. DTS),” where he turns complex skin science into clear, evidence-based K-Beauty guidance. At DermaDAO, Dr. Kim connects cutting-edge dermatology, real-world clinic insights, and community-driven research to shape the future of decentralized skin health.

Hyeon Pyo Jhun

CEO and Lead Chemist of a top research-driven Korean cosmetics manufacturer, with over 40 years of expertise in high-performance skincare R&D and formulation. As DermaDAO’s chemist, Mr. Jhun oversees formulation integrity, scale-up, and quality systems—ensuring Moon and Sun Drops are grounded in rigorous science, ethical production, and globally trusted standards.

Q3 2025

Formulate and test CE Ferulic + UV filter serums “Moon x Sol Drops”

Q4 2025

Launch $SKIN and seed the DermaLabs project treasury

Open a DTC storefront with a clinically validated CE ferulic formulation

Q1 2026

Release SkinScan to track skin metrics and product impact

Enroll the first SkinScan-tracked community trial for CE Ferulic + UV filter products

Q2 2026

Explore frontier actives (longevity ingredients, bioactive peptides) for new products

Q4 2026

Launch an expanded OTC longevity line targeting wrinkles, hydration, pigmentation, barrier repair

Stay up to date

Get the latest community updates and find out about upcoming DermaLabs developments